Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡